- Global Pharma News & Resources
23-Sep-2019 - 24-Sep-2019

6th Annual Conference on Stroke and Neurological Disorders

  • Location:
    • 47 Churchfield Road, London,UK
    • London
    • London
    • W3 6AY
    • United Kingdom
  • View on a map

ME Conferences has overcome to report the initiation of "6th Annual Conference on Stroke and Neurological Disorders" to be held on September 23-24, 2019 at Dubai, UAE with the creative topic "New Emerging Drifts and Tactics on Stroke and Neurological Disorders".

STROKE MEET 2019 offers the best platform to study, inform and discuss new thoughts, current encounters, medicines, failures and issues related to neurological disorders as well as stroke. It is proceeded by knowledgeable, expert and practiced Neurologists, Neuroscientists, neuro health authorities, neurology nurses and hospitals, stroke consultants, neuro-researchers, neuro health care associates, pharmaceutical companies and a team of many other multidisciplinary authorities and medical device manufacturing company. Stroke Meet 2019 Conference goal is gathering universal experts and eminent people to share and discuss their novel ideas and research work so that it would be beneficial for patients suffering from stroke and neurological disorders. Stroke Meet 2019 objective is to gather the audience from everywhere throughout the world to present current research and to broadcast the new trends in the field of stroke and neurology.

It will be a great platform for the young potential researchers and delegates to breakout sessions, highlighting clinical projects, education, and research studies and also to gain vast knowledge from the Discussion with the Neurologists.

We similarly respect the partnership of scientists, research scholars, surgeons, physicians, science faculty and more spectators, Presidents, CEO's, Delegates and Industrial administrators from Pharmacy and Health care divisions making the summit an ideal stage to arrange, share outlooks and information through interactive keynote, plenary, posters and B2B debates.